Clinical trials used 2.4 mg as the primary endpoint dose, where participants lost an average of 14.9% of body weight over 68 weeks
You can get a one-month supply of Wegovy, a semaglutide drug approved specifically for weight loss, for a $50 copay through that program if you have a Medicare Part D prescription drug plan from Aetna or any other insurance provider
A new study published in The BMJ , led by a team from the University of Pennsylvania, looks specifically at how GLP-1 drugs compared to two other common diabetes treatments SGLT-2 inhibitors and DPP-4 inhibitors for people with type 2 diabetes
Not every TRT patient needs peptides, but when they do, the provider overseeing your care can recommend compounds that actually work for your specific situation, not just what's trendy or profitable
When to Consult Your Provider While nighttime injections are safe for the vast majority of people, your specific medical history matters
cGMP, cyclic guanosine monophosphate